The clinical study aims to evaluate a vaccine for avian influenza A (H7N9) delivered by Vaxxas’ high-density microarray patch (HD-MAP), and is funded by the United States government as a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback